Clinical Trial Update: Effect Camostat for Kidney Protection in Chronic Kidney Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Camostat for protecting kidney function in chronic kidney disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Camostat (camostat mesylate)

Snippet

Sponsor: Odense University Hospital | Conditions: Chronic Kidney Disease(CKD) | Phase 2 | Status: RECRUITING